logo
Select company
Select metric
-150.71%EBIT Margin
VS
Market
11
Sector
35
Industry
20
History
60
$ 2.66Close
$ 2.45 - $ 65.4 52-Week Range
Ticker Information

Ticker

BIAF

Company Name

BIOAFFINITY TECHNOLOGIES INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

BIOAFFINITY TECHNOLOGIES INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BIAF - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -11.58M-150.71%$ 7.68M
3/31/2025$ -9.64M-109.4%$ 8.81M
12/31/2024$ -8.94M-95.45%$ 9.36M
9/30/2024$ -8.34M-89.02%$ 9.37M
6/30/2024$ -8.64M-118.13%$ 7.32M
3/31/2024$ -8.29M-167.97%$ 4.94M
12/31/2023$ -7.88M-311.11%$ 2.53M
9/30/2023$ -7.15M-2223.99%$ 321.49K
6/30/2023$ -8.9M-36845.98%$ 24.16K
3/31/2023$ -6.85M-119774.73%$ 5.72K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOAFFINITY TECHNOLOGIES INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, BIOAFFINITY TECHNOLOGIES INC's average EBIT % has been -25170.56%.
  • The median EBIT % for BIOAFFINITY TECHNOLOGIES INC during this period was -167.97%
  • BIOAFFINITY TECHNOLOGIES INC reached its highest EBIT % over the past 5 years at -89.02%.
  • The lowest EBIT % recorded by BIOAFFINITY TECHNOLOGIES INC in the same timeframe -119774.73%

BIOAFFINITY TECHNOLOGIES INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ISPC : ISPECIMEN INC -169.69%IVF : INVO FERTILITY INC -406.79%BNBX : APPLIED DNA SCIENCES INC -399.87%NUWE : NUWELLIS INC -49.51%BMRA : BIOMERICA INC -93.62%HIND : VYOME HOLDINGS INC -68.97%INM : INMED PHARMACEUTICALS INC -157.62%CSCIF : COSCIENS BIOPHARMA INC -187.81%EVOK : EVOKE PHARMA INC -38.16%CPHI : CHINA PHARMA HOLDINGS INC -80.46%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: EBIT [ $ -5.32M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

BIAF - EBIT Margin, Last 5 years

-119774.73%

Minimum

Mar 31, 2023

-89.02%

Maximum

Sep 30, 2024

-25170.56%

Average

-167.97%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%